Covered recipient · General Payments record
GERALD V CURLEY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$6,261.72
- Reported across 384 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $698.25 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $281.57 | 21 |
| Medtronic, Inc. | $168.82 | 1 |
| Lilly USA, LLC | $85.19 | 5 |
| PFIZER INC. | $49.68 | 2 |
| GlaxoSmithKline, LLC. | $33.33 | 2 |
| ABBVIE INC. | $31.03 | 2 |
| Amgen Inc. | $17.75 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $16.24 | 1 |
| Philips Electronics North America Corporation | $14.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.60 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103522894 | CMS |
| ABBVIE INC. | $13.43 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103522896 | CMS |
| Amgen Inc. | $17.75 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117231917 | CMS |
| Boston Scientific Corporation | $16.24 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092437113 | CMS |
| GlaxoSmithKline, LLC. | $18.09 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116420069 | CMS |
| GlaxoSmithKline, LLC. | $15.24 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116470610 | CMS |
| Lilly USA, LLC | $18.45 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135008011 | CMS |
| Lilly USA, LLC | $17.77 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135008013 | CMS |
| Lilly USA, LLC | $14.42 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134978000 | CMS |
| Lilly USA, LLC | $15.05 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134986696 | CMS |
| Lilly USA, LLC | $19.50 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135000882 | CMS |
| Medtronic, Inc. | $168.82 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119310562 | CMS |
| Novo Nordisk Inc | $20.26 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097156848 | CMS |
| Novo Nordisk Inc | $6.13 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096968885 | CMS |
| Novo Nordisk Inc | $22.57 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096985665 | CMS |
| Novo Nordisk Inc | $9.33 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096750935 | CMS |
| Novo Nordisk Inc | $5.93 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097014735 | CMS |
| Novo Nordisk Inc | $8.27 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097255490 | CMS |
| Novo Nordisk Inc | $22.59 | 06/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097472073 | CMS |
| Novo Nordisk Inc | $17.83 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097820822 | CMS |
| Novo Nordisk Inc | $14.04 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096690143 | CMS |
| Novo Nordisk Inc | $3.32 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097045679 | CMS |
| Novo Nordisk Inc | $4.00 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097288213 | CMS |
| Novo Nordisk Inc | $3.01 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097298233 | CMS |
| Novo Nordisk Inc | $3.88 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096803086 | CMS |
| Novo Nordisk Inc | $22.59 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096661787 | CMS |
| Novo Nordisk Inc | $5.74 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096571078 | CMS |
| Novo Nordisk Inc | $17.26 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096822222 | CMS |
| Novo Nordisk Inc | $23.69 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096907437 | CMS |
| Novo Nordisk Inc | $18.02 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096683128 | CMS |
| Novo Nordisk Inc | $22.72 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096602051 | CMS |
| Novo Nordisk Inc | $23.72 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097128792 | CMS |
| Novo Nordisk Inc | $6.67 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097700560 | CMS |
| PFIZER INC. | $25.09 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131090826 | CMS |
| PFIZER INC. | $24.59 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131548836 | CMS |
| Philips North America LLC | $14.64 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146854137 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.